Phase 1 Pseudomonas aeruginosa Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients

Bacterial InfectionsBronchiectasis AdultBronchiectasis With Pseudomonas Aeruginosa Colonization

Centauri Therapeutics Limited104 enrolled1 locationNCT07708116

Recruiting

Phase 1Phase 2

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Pseudomonas aeruginosaCystic Fibrosis LungRespiratory Infections, Recurrent, Chronic

Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088